Nakoda Group of Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 20, 2025, 10:47 pm

Competitors of Nakoda Group of Industries Ltd

All Competitor Stocks of Nakoda Group of Industries Ltd

Quarterly Result

Last Updated: August 21, 2025, 2:15 pm

Below is a detailed analysis of the quarterly data for Nakoda Group of Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 6.92 Cr.. The value appears to be declining and may need further review. It has decreased from 13.98 Cr. (Mar 2025) to 6.92 Cr., marking a decrease of 7.06 Cr..
• For Expenses, as of Jun 2025, the value is 6.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.42 Cr. (Mar 2025) to 6.09 Cr., marking a decrease of 10.33 Cr..
• For Operating Profit, as of Jun 2025, the value is 0.83 Cr.. The value appears strong and on an upward trend. It has increased from -2.44 Cr. (Mar 2025) to 0.83 Cr., marking an increase of 3.27 Cr..
• For OPM %, as of Jun 2025, the value is 11.99%. The value appears strong and on an upward trend. It has increased from -17.45% (Mar 2025) to 11.99%, marking an increase of 29.44%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Interest, as of Jun 2025, the value is 0.33 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.55 Cr. (Mar 2025) to 0.33 Cr., marking a decrease of 0.22 Cr..
• For Depreciation, as of Jun 2025, the value is 0.30 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.28 Cr. (Mar 2025) to 0.30 Cr., marking an increase of 0.02 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.20 Cr.. The value appears strong and on an upward trend. It has increased from -3.27 Cr. (Mar 2025) to 0.20 Cr., marking an increase of 3.47 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from -25.38% (Mar 2025) to 25.00%, marking an increase of 50.38%.
• For Net Profit, as of Jun 2025, the value is 0.16 Cr.. The value appears strong and on an upward trend. It has increased from -2.44 Cr. (Mar 2025) to 0.16 Cr., marking an increase of 2.60 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.09. The value appears strong and on an upward trend. It has increased from -1.37 (Mar 2025) to 0.09, marking an increase of 1.46.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 12:54 pm

Growth

Last Updated: September 5, 2025, 3:46 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Nakoda Group of Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -2.51. This value is below the healthy minimum of 5. It has decreased from -1.77 (Mar 24) to -2.51, marking a decrease of 0.74.
• For Diluted EPS (Rs.), as of Mar 25, the value is -2.51. This value is below the healthy minimum of 5. It has decreased from -1.77 (Mar 24) to -2.51, marking a decrease of 0.74.
• For Cash EPS (Rs.), as of Mar 25, the value is -1.57. This value is below the healthy minimum of 3. It has decreased from -0.81 (Mar 24) to -1.57, marking a decrease of 0.76.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 17.74. It has increased from 15.22 (Mar 24) to 17.74, marking an increase of 2.52.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 17.74. It has increased from 15.22 (Mar 24) to 17.74, marking an increase of 2.52.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 29.42. It has decreased from 37.03 (Mar 24) to 29.42, marking a decrease of 7.61.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -1.26. This value is below the healthy minimum of 2. It has decreased from 0.31 (Mar 24) to -1.26, marking a decrease of 1.57.
• For PBIT / Share (Rs.), as of Mar 25, the value is -2.01. This value is below the healthy minimum of 0. It has decreased from -0.53 (Mar 24) to -2.01, marking a decrease of 1.48.
• For PBT / Share (Rs.), as of Mar 25, the value is -3.09. This value is below the healthy minimum of 0. It has decreased from -2.25 (Mar 24) to -3.09, marking a decrease of 0.84.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -2.32. This value is below the healthy minimum of 2. It has decreased from -1.66 (Mar 24) to -2.32, marking a decrease of 0.66.
• For PBDIT Margin (%), as of Mar 25, the value is -4.28. This value is below the healthy minimum of 10. It has decreased from 0.84 (Mar 24) to -4.28, marking a decrease of 5.12.
• For PBIT Margin (%), as of Mar 25, the value is -6.83. This value is below the healthy minimum of 10. It has decreased from -1.45 (Mar 24) to -6.83, marking a decrease of 5.38.
• For PBT Margin (%), as of Mar 25, the value is -10.51. This value is below the healthy minimum of 10. It has decreased from -6.06 (Mar 24) to -10.51, marking a decrease of 4.45.
• For Net Profit Margin (%), as of Mar 25, the value is -7.87. This value is below the healthy minimum of 5. It has decreased from -4.49 (Mar 24) to -7.87, marking a decrease of 3.38.
• For Return on Networth / Equity (%), as of Mar 25, the value is -13.05. This value is below the healthy minimum of 15. It has decreased from -10.93 (Mar 24) to -13.05, marking a decrease of 2.12.
• For Return on Capital Employeed (%), as of Mar 25, the value is -10.89. This value is below the healthy minimum of 10. It has decreased from -2.88 (Mar 24) to -10.89, marking a decrease of 8.01.
• For Return On Assets (%), as of Mar 25, the value is -8.69. This value is below the healthy minimum of 5. It has decreased from -5.20 (Mar 24) to -8.69, marking a decrease of 3.49.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 0.2. It has decreased from 0.17 (Mar 24) to 0.03, marking a decrease of 0.14.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.44. This value is within the healthy range. It has decreased from 0.94 (Mar 24) to 0.44, marking a decrease of 0.50.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.12. It has decreased from 1.15 (Mar 24) to 1.12, marking a decrease of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 2.20. This value is within the healthy range. It has increased from 1.63 (Mar 24) to 2.20, marking an increase of 0.57.
• For Quick Ratio (X), as of Mar 25, the value is 1.20. This value is within the healthy range. It has increased from 0.62 (Mar 24) to 1.20, marking an increase of 0.58.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.09. This value is below the healthy minimum of 4. It has increased from 2.03 (Mar 24) to 3.09, marking an increase of 1.06.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -7.88 (Mar 24) to 0.00, marking an increase of 7.88.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -16.14 (Mar 24) to 0.00, marking an increase of 16.14.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 107.88 (Mar 24) to 0.00, marking a decrease of 107.88.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 116.14 (Mar 24) to 0.00, marking a decrease of 116.14.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -1.17. This value is below the healthy minimum of 3. It has decreased from 0.18 (Mar 24) to -1.17, marking a decrease of 1.35.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.14. This value is below the healthy minimum of 3. It has decreased from 0.02 (Mar 24) to -1.14, marking a decrease of 1.16.
• For Enterprise Value (Cr.), as of Mar 25, the value is 67.56. It has decreased from 82.02 (Mar 24) to 67.56, marking a decrease of 14.46.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.46. This value is within the healthy range. It has decreased from 1.74 (Mar 24) to 1.46, marking a decrease of 0.28.
• For EV / EBITDA (X), as of Mar 25, the value is -34.06. This value is below the healthy minimum of 5. It has decreased from 205.73 (Mar 24) to -34.06, marking a decrease of 239.79.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.20. This value is within the healthy range. It has decreased from 1.36 (Mar 24) to 1.20, marking a decrease of 0.16.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 107.88 (Mar 24) to 0.00, marking a decrease of 107.88.
• For Price / BV (X), as of Mar 25, the value is 1.99. This value is within the healthy range. It has decreased from 3.31 (Mar 24) to 1.99, marking a decrease of 1.32.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.20. This value is within the healthy range. It has decreased from 1.36 (Mar 24) to 1.20, marking a decrease of 0.16.
• For EarningsYield, as of Mar 25, the value is -0.06. This value is below the healthy minimum of 5. It has decreased from -0.03 (Mar 24) to -0.06, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness